Browse through our press and news section by category:

28.08.2019, Zhejiang Jinyun (China)

SCHOTT builds state-of-the-art plant for high-quality pharmaceutical glass tubing in China

The international technology group SCHOTT held a goundbreaking ceremony for its greenfield pharmaceutical glass tubing plant in Jinyun, Zhejiang.

The capacity expansion comes at a time when China is aspiring to become an innovative global powerhouse. Particularly the pharmaceutical sector plays a key role within China’s innovation roadmap, which is moving from manufacturing generics to new drug development. This shift is further underlined by the “Healthy China 2030” initiative. Subsequently, there is a high demand for premium pharmaceutical packaging made out of Type I pharmaceutical glass in the local market. The demand for high quality drug packaging products is further underlined through government initiatives and ever-growing patient safety standards. The new plant will enable SCHOTT to participate in the advancement of the Chinese pharmaceutical packaging industry. SCHOTT will invest 60 million Euros in the first phase to install a yearly capacity of up to 20.000 tons. The production is scheduled to start at the end of 2020.
The new plant will supply the Chinese domestic pharmaceutical packaging market to aid its development. “We believe that healthy people make for a thriving society,” comments Dr Patrick Markschläger, Executive Vice President of SCHOTT AG Business Unit Tubing. “SCHOTT has the experience, heritage and foresight to help make China’s vision “Healthy China 2030” become reality.”

The plant will manufacture FIOLAX® glass tubing, which is a 5.0 middle borosilicate glass. Hence, the manufacturing site will support the move away from the low borosilicate glass (so called 7.0 glass type) to the higher quality middle borosilicate glass (so called 5.0 glass type), which is already well established globally. Production will be based on SCHOTT’s unique perfeXion® process with 100% quality control of each individual tube and in accordance with the worldwide quality criteria of SCHOTT Tubing.

On the significance of this new plant, Ms. Cai Hong, Chief Secretary of CNPPA remarked that “SCHOTT’s efforts in advancing pharmaceutical packaging safety in China is greatly welcomed. We look forward to SCHOTT’s participation and leadership in providing localized products and services for the Chinese market, as it is an excellent opportunity for mutual learning and sharing of expertise.”

 “The new plant will bring us even closer to decision makers and our customers. With strong support from local authorities, together we can serve the Chinese population with the highest quality glass tubing for safe pharmaceutical packaging,” remarked Chen Huanyu, Tubing greenfield project manager.

The plant in Jinyun is an important link in deepening the global footprint for SCHOTT and will function as a manufacturing hub for the fast growing Chinese market. As the plant moves towards completion, SCHOTT welcomes qualified professionals to join in team.

SCHOTT is a leading international technology group in the areas of specialty glass, glass-ceramics and related high-tech materials. With over 130 years of experience, the company is an innovative partner to many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT has a global presence with production sites and sales offices in 34 countries. In the 2017/2018 fiscal year, the group generated sales of EUR 2.08 billion with over 15,500 employees. SCHOTT AG has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. This is one of the oldest private and largest science-promoting foundations in Germany. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment.
Press contact
Joana Kornblum
PR & Communication Manager
Pharma | Medical | Diagnostics
Hattenbergstraße 10
55122 Mainz
Phone: +49 6131/66-4073